<br><div class="old-content"><style></style><div class="old-content"><div class="old-content"><strong>Certara </strong><div class="old-content"><div class="old-content">&nbsp;</div><div class="old-content">Based on an <em>in-silico</em>model of human ventricular heart cells, Certara's Cardiac Safety Simulator(CSS) helps sponsors to assess arrhythmia risk before a new drug candidateenters clinical trials and determine safe drug doses for specific patientpopulations.<div class="old-content"><div class="old-content">&nbsp;</div><div class="old-content"><strong>Certara </strong><div class="old-content"><br><a target="_blank" href="http://www.certara.com/ ">www.certara.com</a><div class="old-content">&nbsp;&nbsp;</div></div></div></div></div></div></div></div>&nbsp;</div>

October 2013

Based on an in-silico model of human ventricular heart cells, Certara’s Cardiac Safety Simulator (CSS) helps sponsors to assess 

arrhythmia risk before a new drug candidate enters clinical trials and determine safe drug doses for specific patient populations. 

Internal Medicine

Certara launches Cardiac Safety Simulator to determine arrhythmia 

risk for drug candidates

Article

Articles

1-0325-cover

March 2025

Research Areas

A blue x-ray style image of a human body is shown with the liver illuminated in orange against a dark blue background.  

untitled-design-2025-03-12t163253-386

cn-bio-logo-colour-300mm

CN Bio

Discover how researchers leverage microphysiological systems in toxicology studies. &nbsp;

Harnessing liver-on-a-chip models for drug safety

Webinars

A person wearing a white lab coat types on a laptop with various overlaid enlarged files shown with plus signs on file folders floating over the laptop screen with a clinical lab shown in the background in grey and white tones.

78041-1800x900-2

Thermo Fisher Scientific

Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.

Enhancing bioanalytical studies with centralized data management

Whitepaper

A 3D-rendered digital illustration of a molecular structure floating among red blood cells in a bloodstream environment.

untitled-design-2025-03-11t120646-259

takara-bio-inc-logo-vector

Takara Bio

By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.

Explained: How are metabolite biomarkers improving drug discovery and development?

Explainers

Certara Based on an in-silicomodel of human ventricular heart cells, Certara's Cardiac Safety Simulator(CSS) helps sponsors to assess arrhythmia risk before a new drug candidateenters clinical trials and determine safe drug doses for specific patientpopulations. Certara www.certara.com

Based on an in-silico model of human ventricular heart cells, Certara’s Cardiac Safety Simulator (CSS) helps sponsors to assess 

arrhythmia risk before a new drug candidate enters clinical trials and determine safe drug doses for specific patient populations.

Related Topics

Published In

October 2013

Subscribe to our eNewsletters

Sponsored

Harnessing liver-on-a-chip models for drug safety

Enhancing bioanalytical studies with centralized data management

Explained: How are metabolite biomarkers improving drug discovery and development?

March 2025